[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Editor's Correspondence
December NaN, 2002

Risk of Myocardial Infarction Associated With Selective COX-2 Inhibitors: Questions Remain—Reply

Arch Intern Med. 2002;162(22):2641. doi:

In reply

Two clinical trials found that the incidence of MI in those who use rofecoxib was similar to that in those who use ibuprofen or diclofenac.1,2 The VIGOR study found an increased risk of MI with rofecoxib compared with naproxen.3

First Page Preview View Large
First page PDF preview
First page PDF preview